Are you getting the attention you need from your current central lab?

Barc Lab aspires to partner with you to develop bespoke, optimized solutions for your projects to ensure success of your treatments and improve patients’ lives. With more than 35 years of experience, 375 ongoing clinical trials, and divisions in 5 continents, we have the expertise, scientific knowledge, and technology needed to help you achieve your goals. 

THERAPEUTIC AREAS

We can meet you anywhere to deliver a unique plan for any of these key therapeutic areas, and support clients in every step of their clinical trials.

Our mission is to partner with you to bring personalized medicine to patients and
allow you to focus on what matters most: Improving healthcare and quality of life.

Oncology

As a global leader in oncology trials, we can keep you on track and beyond in this ever-evolving field.

NASH

We support the biggest phase 3 study in NASH so far, in search of a better diagnosis and treatment.

Infectious diseases

We offer flexible assays, fast and secure diagnostic opportunities, and can react quickly to new
infectious threats with the development of new tests.

Inflammatory disorders

Our specialists are committed to help you determine which tests could be implemented making your
study in inflammatory disorders more informative and less risky.

We can provide you with the solution you need by tapping on to our broad testing portfolio, ranging from Flow Cytometry, Histopathology, PK and Biomarker testing, NGS, Microbiology and any other esoteric & routing testing.

Learn more

Go to article: Home | Advancing adherenceGo to article: Scandinavian Health Company InsightGo to article: Scandinavian Health Ltd.Go to article: EditorialGo to article: PfanstiehlGo to article: Pfanstiehl Company InsightGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: Owen MumfordGo to article: NewsGo to article: TSS Company InsightGo to article: TSS ABGo to article: Novo NordiskGo to article: The pharma industry briefingGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Timeline: using viruses to fight diseaseGo to article: Swiss WorldCargoGo to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Q&A: an eye on innovation with SparingVisionGo to article: MasterpackGo to article: Molnar Company InsightGo to article: MolnarGo to article: B&W TekGo to article: Could smart pill bottles dispense a solution to drug non-adherence?Go to article: Hapa Company InsightGo to article: Qatar AirwaysGo to article: Dow EuropeGo to article: WHO’s Essential Medicines List: discussing innovation and accessGo to article: Erdmann Design SwitzerlandGo to article: AEB Company Insight Go to article: AEBGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Are we nearing the end of animal testing in pharma?Go to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Barc Lab Go to article: Why is pharma so bad at sharing clinical trial data?Go to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Capsugel Company InsightGo to article: Unseen genes: boosting African DNA in medical researchGo to article: Emirates SkyCargoGo to article: Pfeiffer VacuumGo to article: Could Netflix-style subscription models work for medicines?Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: MicronovaGo to article: AlpexGo to article: EventsGo to article: Senn Chemicals Company InsightGo to article: Senn ChemicalsGo to article: ICCI Company InsightGo to article: ICCIGo to article: Next issueGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Nemera Company InsightGo to article: NemeraGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: MimotopesGo to article: Baxter